News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

FluoroPharma Announces the Promotion of Tamara Rhein to CFO


8/23/2012 10:08:33 AM

MONTCLAIR, N.J., Aug. 22, 2012 (GLOBE NEWSWIRE) -- FluoroPharma Medical, Inc. (OTCBB:FPMI), a company specializing in the development of novel diagnostic imaging products that utilize positron emission tomography (PET) technology for the detection and assessment of disease before clinical manifestation, is pleased to announce the promotion of Tamara Rhein to the position of Chief Financial Officer. Ms. Rhein will report directly to Thijs Spoor, FluoroPharma's Chairman, President and Chief Executive Officer. "I am delighted to promote Tamara Rhein to CFO. Since she joined FluoroPharma, she has become a valuable asset to our business. Her strong background in finance and experience in prestigious investment firms, Pharmaceuticals as well as small start-up companies further strengthens our management team," commented Mr. Spoor.

Read at GlobeNewswire

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES